IMD WATCH
LOW-PROTEIN FOODS: COSTEFFECTIVE PRESCRIBING Inherited metabolic disorders (IMD) of amino acid metabolism require life-long management with a low-protein diet.1 Prescribing of low-protein foods for dietary management of IMD is essential. This article reports on the issues surrounding cost-effective prescribing in England. Catherine Kidd Dietitian, Great Ormond Street Hospital for Children, NHS Trust, London Catherine is a Paediatric Dietitian, with acute clinical experience in a range of specialities including cardiology, oncology/ haematology, paediatric intensive care and metabolics.
REFERENCES Please visit the Subscriber zone at NHDmag.com
Catherine would like to acknowledge the metabolic dietitians team at Great Ormond Street Hospital for their contribution and review of this article.
40
IMD of amino acid metabolism include phenylketonuria (PKU), maple syrup urine disease, tyrosinaemia and homocystinuria. Together, natural protein restriction, L-amino acid supplementation and low-protein prescribed foods form the dietary management. Patients require an ongoing supply of low-protein foods to be prescribed by their GP. For patients with PKU, these foods can provide up to 50% of daily energy intake, add bulk to the diet and help with adherence by providing choice in a very limited diet.2 If these products are not prescribed, or provided in adequate amounts, then biochemical control and metabolic stability can be compromised, due to energy deficit and resultant catabolism. Good dietary management and biochemical control are essential to achieve normal growth and optimal neurological outcome in these IMD. THE SCOPE OF THE ISSUE IN ENGLAND
In England, it is estimated that around 10,000 patients attend metabolic clinics. Unfortunately, data is not currently available on the number of patients requiring a low-protein diet with prescribed low-protein foods.3 PKU is the most common diagnosis requiring a low-protein diet, with an estimated 2500 patients with PKU ‘on diet’ in the UK, with a further 60 to 70 new diagnoses per year.3 At our centre, around 220 patients (of which 180 have PKU), aged 0-18 years are on low-protein diets with prescribed low-protein foods. The overall cost of low-protein diets (low-protein food and L-amino acid supplement) to the NHS is estimated
www.NHDmag.com June/July 2019 - Issue 145
to be in the region of £12,000 to £18,000 per PKU patient per year, with costs varying according to patient age.1 Approximately 20% of this cost is attributed to food.1 Therefore, at our centre, low-protein food prescriptions for PKU patients alone may cost in the region of £480,000 to £720,000. Clearly, appropriate prescribing of low-protein food is essential in an increasingly financially pressured NHS. THE ROLE OF THE LONDON PROCUREMENT PARTNERSHIP (LPP) IN APPROPRIATE PRESCRIBING
The LPP is a membership organisation founded and funded by London NHS trusts, which supports the NHS to make the most of its purchasing power, so that it can maximise investment in patient care.4 The LPP has produced guidelines on appropriate prescribing of IMD, which clearly state that prescribed low-protein products are essential for the management of IMD patients, and interruptions to their prescription should be avoided, otherwise metabolic control may be lost.4 The LPP states that metabolic dietitians should monitor product usage and prescriptions. However, the LPP also states that metabolic products (including low-protein foods) should not be confused with areas suitable for prescribing review, and should be classified as ‘essential’ rather than ‘staple’ or ‘luxury’. THE ROLE OF THE ADVISORY COMMITTEE ON BORDERLINE SUBSTANCES (ACBS)
The ACBS is responsible for advising on the prescribing of nutritional and dermatological products for use in NHS